definiens: or Material AdverseEffect ( as defined in the Biolipox - Inflazyme Asset Purchase Agreement ) set forth therein ) would not have aMaterial Adverse Effect ( as defined in the Biolipox - Inflazyme Asset Purchase Agreement ) ; 7.12.2each of Inflazyme Inc., Inflazyme Pharmaceuticals Ltd. and/or Adprotech Limited under the Biolipox - InflazymeAsset Purchase Agreement has complied in all material respects with all covenants and conditions required by theBiolipox - Inflazyme Asset Purchase Agreement to be performed or complied with by it in respect of the AcquiredAssets prior to or at the Closing ( as defined in the Biolipox - Inflazyme Asset Purchase Agreement ) ; and 7.12.3the Contracts referenced under the Biolipox - Inflazyme Asset Purchase Agreement and listed in Schedule 7.12.3do not relate to the LSAIDs